Publications by authors named "Michael Veeder"

Claim this Profile
A
A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors.
David Hong, Drew Rasco, Michael Veeder, Jason J Luke, Jason Chandler

Oncology· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term results of the treatment of patients with mantle cell lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central Cancer Treatment Group.
David J Inwards, Paul A S Fishkin, David W Hillman, David W Brown, Stephen M Ansell, Michael H Veeder

Cancer· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematologic and cytogenetic spontaneous remission in acute monocytic leukemia (FAB M5b) with trisomy 8.
Antoine Daccache, Tinoy Kizhakekuttu, James Siebert, Michael Veeder

J Clin Oncol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of docetaxel and carboplatin as first-line chemotherapy for metastatic breast cancer: NCCTG study N9932.
Edith A Perez, Vera J Suman, Tom R Fitch, James A Mailliard, James N Ingle, Michael H Veeder

Oncology· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer.
Chandra P Belani, Wei Wang, David H Johnson, Henry Wagner, Joan Schiller, Michael Veeder

J Clin Oncol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer: a North Central Cancer Treatment Group Trial.
Patrick A Burch, James A Mailliard, David W Hillman, Edith A Perez, James E Krook, Michael H Veeder

Am J Clin Oncol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis